The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Book Review
PreviousPrevious
Volume 332:403 February 9, 1995 Number 6
NextNext

Sickle Cell Disease: Basic principles and clinical practice

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
Edited by Stephen H. Embury, Robert P. Hebbel, Narla Mohandas, and Martin H. Steinberg. 902 pp., illustrated. New York, Raven Press, 1994. $145. ISBN 0-7817-0142-2.

Hemoglobin S arose as a protection against malarial infection. However, it has also given rise to untold misery, pain, and suffering in hundreds of thousands of people who happen to be homozygous for the sickle-cell gene. The multiple causes of the disease and its complications have been meticulously studied. There are now few diseases that are better understood — biochemically, pathophysiologically, clinically, and pharmacologically — than sickle cell disease. Yet this knowledge has yielded few therapeutic interventions other than those used to treat complications or symptoms of the disease. Recently, though, quantum leaps in scientific technology indicate that a cure . . . [Full Text of this Article]




HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.